SUMMIYA AZEEM-Kech ...

Vir Biotechnology, Inc.’s VIR share price has dipped by 5.45%, which has investors questioning if this is right time to buy.

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

After the monoclonal antibody nirsevimab (Beyfortus) became available to prevent respiratory syncytial virus (RSV) in infants ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

Icosavax’s pipeline of respiratory disease vaccines is headed by IVX-A12, a virus-like particle (VLP) shot that targets both RSV and human metapneumovirus (hMPV), two major causes of serious ...

Sanofi has a plan to make it a ‘backbone’ of a combination respiratory vaccine that could include other components such as human metapneumovirus and parainfluenza virus. The drugmaker will ...

The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called ...